| Autor: |
Monti, Marta, Martini, Tiziano, Pengo, Vittorio, Poletti, Giovanni, Pedrazzi, Paola, Biasoli, Chiara, Giovacchini, Maddalena, Fasano, Tommaso |
| Předmět: |
|
| Zdroj: |
Seminars in Thrombosis & Hemostasis; Jul2023, Vol. 49 Issue 5, p558-560, 3p |
| Abstrakt: |
Diagnosis of LAC (lupus anticoagulant) was made on day 3 and was associated with high titer aPS/PT (anti phosphatidyl-serine/prothrombin) antibodies of IgG isotype. Among the tests that study the presence of circulating antiphospholipid antibodies, the so-called lupus anticoagulant (LA) is considered the main risk factor for venous and arterial thromboembolic disease. [6] Like most cases of LA and antiphospholipid antibodies reported to be associated with COVID-19, [7][8] the LA in our case was transient and not the characteristic of an antiphospholipid (antibody) syndrome. [Extracted from the article] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
